Table 3.
Epitope typea | # of Epitopes recognizedb | Target protein characteristicsc |
---|---|---|
B cell | 9–15 ORFs (# of ORFs per subject not ascertained) | Predominantly proteins with late or early/late promoters. Almost exclusively membrane and core proteins |
CD4+ T cell | >130 ORFs (~0–20 ORFs per subject) | Early, intermediate and late proteins, predominantly structural and membrane proteins as well as DNA replication enzymes. |
CD8+ T cell | >190 ORFs epitope diversity within individuals is not well studied. Most subjects recognized more than 1 epitope. |
Predominantly early proteins. Multiple functional categories (virulence factors, viral replication enzymes, transcription factors, structural proteins) are targeted by CTL. |
Immune epitopes from VACV.
Lymphocyte subset recognizing each group of epitopes.
Top number represents the total # of ORFs for which epitopes have been identified. The number(s) in parentheses indicate the extent or diversity of antigenic recognition on a per subject basis.